Related Experiment Video
Updated: Aug 7, 2025
04:41
Mapping Alzheimer's Disease Variants to Their Target Genes Using Computational Analysis of Chromatin Configuration
Published on: January 9, 2020
19.0K
Reply to: "Aberrant GAP43 Gene Expression Is Alzheimer Disease Pathology-Specific"
Guoyu Lan1, Tengfei Guo1,2
1Institute of Biomedical Engineering, Shenzhen Bay Laboratory, Shenzhen, China.
Annals of Neurology
|March 10, 2023
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
01:26Alzheimer's Disease: Overview
575
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
575
01:22Alzheimer's Disease: Treatment
233
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
233